- B2B
- Early StageStartup in initial stages
- Top InvestorsThis company has received a significant amount of investment from top investors
- YC FundedStartup funded by Y Combinator
- Website
- Location
- Company size
- 11-50 people
- Total raised
- $6.2M
- Markets
CB Therapeutics careers
CB Therapeutics is an innovative producer of high value molecules, compounds and rare ingredients from simple feedstock utilizing many different types of hosts and systems, including yeast and cell-free expression systems. Our expertise in
synthetic genomics, bio-engineering and cellular production processes have produced a broad range of compounds faster, more sustainably, at greater yields and with higher purity, consistency and efficiency than competitive platforms.
CB Therapeutics has assembled a team with deep expertise in synthetic genomics and bio-engineering that has significantly advanced our proprietary yeasts, enzymes and production processes to advance the science of cellular agriculture. Our high
throughput Bio-Informatics platform seeks, filters and discovers the unique and optimal enzymes from plants and other sources to domesticate for our novel production yeast and bacteria strains as well as cell-free expression processes. We have 2 granted patents, and 6 pending applications.
We have built and refined a 7000+ sf fully-licensed commercial batch facility in southern California including research labsand a production facility for laboratory scale and pilot production runs. The facility is equipped with an extensive suite of micro scale, bench top and large scale bioreactor systems to optimize our production processes for a broad range of high value molecules, compounds and rare ingredients.
Cannabinoids and Tryptamines derived from plants and fungi have attracted significant interest for the treatment of multiple diseases and disorders. The demand for CBD has exploded as pharmaceuticals nutraceuticals, tinctures, topical creams and functional foods and beverages. As Cannabis and Tryptamines becomes legal in more U.S. States and the world, demand for more high quality, pharmaceutical-grade compounds has also significantly increased.
Potential Therapeutic categories include:
• Anxiety • Insomnia • Depression • Chronic Pain • Inflammation
synthetic genomics, bio-engineering and cellular production processes have produced a broad range of compounds faster, more sustainably, at greater yields and with higher purity, consistency and efficiency than competitive platforms.
CB Therapeutics has assembled a team with deep expertise in synthetic genomics and bio-engineering that has significantly advanced our proprietary yeasts, enzymes and production processes to advance the science of cellular agriculture. Our high
throughput Bio-Informatics platform seeks, filters and discovers the unique and optimal enzymes from plants and other sources to domesticate for our novel production yeast and bacteria strains as well as cell-free expression processes. We have 2 granted patents, and 6 pending applications.
We have built and refined a 7000+ sf fully-licensed commercial batch facility in southern California including research labsand a production facility for laboratory scale and pilot production runs. The facility is equipped with an extensive suite of micro scale, bench top and large scale bioreactor systems to optimize our production processes for a broad range of high value molecules, compounds and rare ingredients.
Cannabinoids and Tryptamines derived from plants and fungi have attracted significant interest for the treatment of multiple diseases and disorders. The demand for CBD has exploded as pharmaceuticals nutraceuticals, tinctures, topical creams and functional foods and beverages. As Cannabis and Tryptamines becomes legal in more U.S. States and the world, demand for more high quality, pharmaceutical-grade compounds has also significantly increased.
Potential Therapeutic categories include:
• Anxiety • Insomnia • Depression • Chronic Pain • Inflammation
CB Therapeutics hasn't added any jobs yet
Get notified when CB Therapeutics posts new jobs.
Jacob Vogan
Total raised
$6.2M
Funded over
2 rounds
Latest round
Seed (Jan 2019)
Quartzy • Houston • 3 weeks ago
Penumbra • Berlin • 3 weeks ago
Classy.org • United States • $125k – $170k • 3 weeks ago
Houzz • Nepal • 4 weeks ago